Fulgent Genetics logo

Director of Bioanalytical Sciences

Fulgent Genetics

Newark, DEOnsitePosted 2 days ago
Full TimeDirector & AboveResearch & ScientistDiagnostics
Original posting ↗

Summary

The Director of Bioanalytical Services is a hands-on CMC analytical leader responsible for running Fulgent Pharma's analytical development and QC capabilities to support our oncology pipeline from early development through clinical stages and eventual commercialization. This role combines strategic ownership of analytical control strategy with direct laboratory execution, vendor oversight, and cross-functional leadership typical of a small, fast-moving biotech environment.

Job description

Summary of Position

The Director of Bioanalytical Services is a hands-on CMC analytical leader responsible for running Fulgent Pharma's analytical development and QC capabilities to support our oncology pipeline from early development through clinical stages and eventual commercialization. This role combines strategic ownership of analytical control strategy with direct laboratory execution, vendor oversight, and cross-functional leadership typical of a small, fast-moving biotech environment.

The Director will establish analytical methods, systems, and workflows, ensuring phase-appropriate rigor, regulatory compliance, and efficient use of internal and external resources. This position is ideal for a leader who thrives in a startup-style environment, enjoys solving multidisciplinary problems, and is comfortable switching between high-level CMC strategy and bench-level execution.

Analytical Strategy & Execution

  • Own the analytical control strategy for drug products and novel excipients across all phases.
  • Develop, qualify, validate, and troubleshoot analytical methods (HPLC/UHPLC, LC-MS/MS, GC, SEC, DLS, solid-state, microbiological, etc.).
  • Design and execute forced degradation, stability-indicating method development, and characterization studies.
  • Establish practical, phase-appropriate specifications and update them as programs mature.

Hands-On Laboratory Leadership

  • Work directly at the bench (10-30% depending on phase) to develop methods, generate data, and mentor scientists.
  • Oversee day-to-day lab operations, instrument strategy, qualification, and troubleshooting.

CRO/CMO Oversight

  • Lead method transfers, qualifications, and ongoing oversight of CROs and CMOs.
  • Ensure data integrity, technical alignment, and timely delivery of outsourced analytical work.
  • Participate in vendor audits and selection.

Regulatory & CMC Ownership

  • Serve as analytical lead for IND/IMPD filings and contribute to NDA/DMF content.
  • Draft and review analytical sections of Module 3.
  • Support responses to FDA/EMA information requests and inspection readiness.

Quality, Compliance & Data Integrity

  • Ensure adherence to GMP, ICH, and FDA expectations appropriate for clinical-stage biotech.
  • Implement practical data integrity controls, documentation standards, and 21 CFR Part 11 practices.
  • Lead OOS/OOT investigations, CAPA and analytical improvements.

Stability & Specifications

  • Own stability program design, execution, and trending.
  • Manage reference standard qualification and lifecycle.
  • Establish and maintain phase-appropriate specifications.

Team Building & Leadership

  • Build and mentor a small, high-impact analytical team.
  • Provide hands-on training, technical guidance, and career development.
  • Create a culture of scientific rigor, urgency, and accountability.

Safety & Lab Infrastructure

  • Ensure safe operation of analytical labs and compliance with chemical/biological safety requirements.
  • Support safety committee activities and continuous improvement of safety practices.

Qualifications: Knowledge/Experience

  • Ph.D. in Analytical Chemistry, Biochemistry, Pharmaceutical Sciences, or related field with 8-15 years of industry experiences.
  • Demonstrated success in leading analytical development.
  • Expert in method development, validation, and troubleshooting across major analytical platforms.
  • Strong understanding of sterile injectable and/or nano-formulation analytical challenges a plus.
  • Experience supporting IND/DMF/NDA filings and interacting with regulatory agencies.
  • Ability to operate effectively in a fast-changing environment.
  • Hands-on leader comfortable working at the bench while driving strategy.
  • Strong documentation, communication, and cross-functional collaboration skills.

Preferred

  • Experience with oncology injectables, lyophilized products, and novel excipients.
  • Experience building analytical labs, systems, or teams.
  • Familiarity with QbD principles and analytical lifecycle management.
  • Ability to manage multiple programs and shifting priorities typical of small biotech.

Requirements

  • Ph.D. in Analytical Chemistry, Biochemistry, Pharmaceutical Sciences, or related field
  • 8-15 years of industry experience
  • Demonstrated success in leading analytical development
  • Expert in method development, validation, and troubleshooting across major analytical platforms
  • Experience supporting IND/DMF/NDA filings and interacting with regulatory agencies
  • Ability to operate effectively in a fast-changing environment
  • Hands-on leader comfortable working at the bench while driving strategy
  • Strong documentation, communication, and cross-functional collaboration skills

Company overview

Fulgent Genetics is a premier, full-service genomic testing company founded in 2011 and headquartered in El Monte, California. As a CLIA-certified and CAP-accredited laboratory, the company provides comprehensive clinical diagnostic solutions including molecular diagnostic testing, genetic testing, anatomic pathology laboratory tests, oncology testing services, and sequencer services related to hereditary cancer, reproductive health, and other diseases. Fulgent operates six laboratories across the United States and offers an extensive testing menu covering over 18,000+ single gene tests, 900+ rare disease tests, whole genome sequencing, and copy number variation analysis. The company has evolved into a technology-driven organization with expertise in genomics, bioinformatics, and artificial intelligence, serving insurance companies, hospitals, medical institutions, governmental bodies, and patients. Through its subsidiaries including Fulgent Oncology, Inform Diagnostics, and CSI Laboratories, Fulgent provides precision medicine solutions focused on transforming patient care in oncology, anatomic pathology, infectious and rare diseases, and reproductive health. The company is publicly traded on NASDAQ under the ticker FLGT and continues to expand its capabilities through strategic acquisitions and technological innovation.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.